Willow vs MedVi: Structured Follow-Up vs Low Promo Price
Quick verdict: Willow vs MedVi splits on support style and price. Willow emphasizes a structured, progress-tracking oral GLP-1 weight management journey with licensed clinician follow-up, while MedVi offers compounded semaglutide with a promotional first month as low as $179 and 24/7 certified medical support. Treatment eligibility and prescriptions are subject to clinician review for both platforms.
Explore Willow’s structured program
How Willow vs MedVi differ at a glance
This comparison focuses on the most distinctive differences supported by the sources: support model and follow-up, medication format and regulatory notes, pricing structure and promos, and the need for clinic visits or online-only care. Where evidence is absent it is noted as not supplied.
Support model and follow-up
Willow positions its program as a telehealth-first weight management journey that pairs oral GLP-1 with progress tracking tools and follow-up consultations conducted by a licensed telehealth team. The source describes Willow as emphasizing behavioral scaffolding and follow-up support to convert medication effects into sustainable outcomes. MedVi highlights 24/7 support from certified medical professionals and 1:1 guidance included with its program. Both platforms require licensed clinician review to determine medical appropriateness; MedVi notes that OpenLoop Health clinicians meet with individuals after checkout and retain prescribing discretion.
See Willow’s follow-up features
Medication format and regulatory notes
Willow markets an oral GLP-1 program and states that compounded medications, when offered, are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. MedVi provides clinically dosed compounded semaglutide and explicitly states its compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. MedVi also clarifies it does not produce compounded medications itself and that compounded products may look different than portrayed. Both platforms emphasize clinician judgment in prescribing.
Pricing structure and promotional details
Willow’s captured evidence lists a starting price of 299 and notes higher monthly entry pricing for some plans as a con; no promo or shipping details were verified on the captured Willow page. MedVi presents a winter promotional first month at $179 including fast, free shipping, with the source warning the ongoing standalone month is $299 and that a three-month plan at $649 reduces per-month cost. MedVi’s materials repeatedly preserve that the $179 rate is promotional and that ongoing price increases occur after the first month.
| Criteria | Willow | MedVi |
|---|---|---|
| Primary offering | Oral GLP-1 with progress tracking and follow-up | Compounded semaglutide delivered after online intake |
| Support | Licensed telehealth team; follow-up consultations | 24/7 certified medical support; 1:1 guidance |
| Pricing (captured) | Starting price: 299 | Promotional first month: $179; then $299 standalone |
| Clinic visits | Telehealth-first (no clinic evidence captured) | No clinic visits required; online intake and clinician review |
| Regulatory note | Compounded medications not FDA-approved when offered | Compounded medications not FDA-approved; produced in regulated facilities but not FDA-evaluated |
Process and eligibility
Both providers use clinician review to determine if treatment is medically appropriate. Willow states treatment is available only when a licensed clinician determines it is medically appropriate. MedVi’s assessment does not create a doctor-patient relationship and OpenLoop Health clinicians determine eligibility after an online assessment and clinician review; clinicians retain discretion to prescribe compounded GLP-1s.
What each emphasizes in marketing
Willow emphasizes a structured weight management journey and behavioral support tools to turn medication into sustainable outcomes. MedVi emphasizes a low promotional entry price, a simple online intake with no clinic visits, and clinically dosed compounded semaglutide with shipping included in the promo.
Compare Willow’s program details
Final take: Willow vs MedVi
Use the primary keyword Willow vs MedVi to frame choice: choose Willow if you prioritize a structured digital follow-up program built around oral GLP-1 and progress tracking with licensed telehealth clinicians. Choose MedVi if your priority is a lower promotional first-month cost for compounded semaglutide, 24/7 certified medical support, and a fully online process with no clinic visits. Both require clinician review and note that compounded medications are not FDA-approved when used.